financetom
Business
financetom
/
Business
/
BlueScope Steel's profit slumps 90% on impairment charge; shares tumble 7%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlueScope Steel's profit slumps 90% on impairment charge; shares tumble 7%
Aug 17, 2025 6:49 PM

(Reuters) -Australia's BlueScope Steel ( BLSFF ) reported a 90% slump in annual profit on Monday, citing an impairment charge at its coated products business and weak performance at its North America operations, sending its shares 7% lower.

Shares of BlueScope, Australia's biggest steel producer, were down at A$22.55, as at 0018 GMT, their lowest point in more than seven weeks. That compared with the broader benchmark index ASX 200, which was down 0.2%.

BlueScope Steel's ( BLSFF ) coated products business in its North American division reported an annual loss, pressured by lower volumes and operational challenges, leading to a one-off impairment charge of A$438.9 million ($285.90 million).

"There has been a delay in achieving our expectations of the BlueScope Coated Products business, which we acquired in 2022, and an impairment of A$439 million has been recorded," the steel producer said.

Its North America division, one of its top profit-generating divisions, posted underlying operating earnings of A$514.4 million in the year ended June 30, down 45% from last year. The drop was primarily due to lower selling prices at its North Star and Buildings and Coated Products North America operations.

As a result, the company's net profit after tax came in at A$83.8 million ($54.6 million) in fiscal 2025, down from A$805.7 million reported in fiscal 2024.

On an underlying basis, exclusing one-off items, BlueScope's profit halved from the previous year to A$420.8 million, pulled down by price pressures, lower volumes, and higher costs. The result also fell short of the Visible Alpha consensus estimate of A$466.4 million.

The company forecast underlying operating earnings for first half of 2026 between A$550 million and A$620 million, above last year's A$309 million, though its midpoint misses the Visible Alpha consensus of A$618 million.

BlueScope declared a final dividend of 30 Australian cents per share, in line with last year.

($1 = 1.5352 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved